Opyl Ltd
Pathkey.AI Ltd engages in the development of digital tools that enhance healthcare experience for patients in Australia. The company offers TrialKey, an AI-driven clinical trial optimization and success prediction platform, that simulate and optimize trial designs for pharmaceuticals, medical devices, alternative therapies, and novel conditions. It also provides TrialGen, an AI-powered tool strea… Read more
Opyl Ltd (OPL) - Net Assets
Latest net assets as of December 2024: AU$-310.99K AUD
Based on the latest financial reports, Opyl Ltd (OPL) has net assets worth AU$-310.99K AUD as of December 2024.
Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets (AU$384.82K) and total liabilities (AU$695.82K). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off.
Key Net Assets Metrics
| Metric | Value |
|---|---|
| Current Net Assets | AU$-310.99K |
| % of Total Assets | -80.81% |
| Annual Growth Rate | N/A |
| 5-Year Change | -112.54% |
| 10-Year Change | -106.8% |
| Growth Volatility | 200.08 |
Opyl Ltd - Net Assets Trend (1996–2024)
This chart illustrates how Opyl Ltd's net assets have evolved over time, based on quarterly financial data. Explore and compare other companies by net assets.
Annual Net Assets for Opyl Ltd (1996–2024)
The table below shows the annual net assets of Opyl Ltd from 1996 to 2024.
| Year | Net Assets | Change |
|---|---|---|
| 2024-06-30 | AU$-90.16K | +77.66% |
| 2023-06-30 | AU$-403.59K | -251.15% |
| 2022-06-30 | AU$267.01K | -87.79% |
| 2021-06-30 | AU$2.19 Million | +204.18% |
| 2020-06-30 | AU$719.18K | +278.54% |
| 2019-06-30 | AU$-402.81K | -128.89% |
| 2018-06-30 | AU$1.39 Million | +503.97% |
| 2017-06-30 | AU$230.83K | -89.60% |
| 2016-06-30 | AU$2.22 Million | +67.38% |
| 2015-06-30 | AU$1.33 Million | -77.05% |
| 2014-06-30 | AU$5.77 Million | -30.54% |
| 2013-06-30 | AU$8.31 Million | -17.87% |
| 2012-06-30 | AU$10.12 Million | -28.55% |
| 2011-06-30 | AU$14.17 Million | +739.22% |
| 2010-06-30 | AU$1.69 Million | +141.80% |
| 2009-06-30 | AU$-4.04 Million | -105.82% |
| 2008-06-30 | AU$69.38 Million | +16.39% |
| 2007-06-30 | AU$59.61 Million | +14.34% |
| 2006-06-30 | AU$52.13 Million | +288.73% |
| 2005-06-30 | AU$13.41 Million | -16.65% |
| 2004-06-30 | AU$16.09 Million | +53.66% |
| 2003-06-30 | AU$10.47 Million | +6.32% |
| 2002-06-30 | AU$9.85 Million | +10.74% |
| 2001-06-30 | AU$8.89 Million | -5.54% |
| 2000-06-30 | AU$9.41 Million | +46.97% |
| 1999-06-30 | AU$6.41 Million | -0.18% |
| 1998-06-30 | AU$6.42 Million | +3.35% |
| 1997-06-30 | AU$6.21 Million | +0.92% |
| 1996-06-30 | AU$6.15 Million | -- |
Equity Component Analysis
This analysis shows how different components contribute to Opyl Ltd's total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.
Equity Composition Insights
- Retained earnings have decreased by 2108181900.0% over the analyzed period, potentially due to dividend distributions or operating losses.
Current Equity Component Breakdown (June 2024)
| Component | Amount | Percentage |
|---|---|---|
| Common Stock | AU$22.50 Million | % |
| Other Comprehensive Income | AU$1.14 Million | % |
| Total Equity | AU$-90.16K | 100.00% |
Opyl Ltd Competitors by Market Cap
The table below lists competitors of Opyl Ltd ranked by their market capitalization.
| Company | Market Cap |
|---|---|
|
LEGRAND (LRC.SG)
STU:LRC
|
$1.28 Million |
|
Tantech Holdings Ltd
NASDAQ:TANH
|
$1.28 Million |
|
Reddit
F:6VO
|
$1.28 Million |
|
IM Co.Ltd
KQ:101390
|
$1.29 Million |
|
Lambo Group Bhd
KLSE:0018
|
$1.28 Million |
|
Vanadiumcorp Resource Inc
PINK:VRBFF
|
$1.28 Million |
|
Maytronics
TA:MTRN
|
$1.28 Million |
|
CONSTELLATION BRD-A
MU:CB1A
|
$1.28 Million |
Equity Growth Attribution
This analysis shows how different factors contributed to changes in Opyl Ltd's equity between the two most recent reporting periods.
Equity Growth Insights
- From 2023 to 2024, total equity changed from -403,586 to -90,160, a change of 313,426.
- Net loss of 3,130,000 reduced equity.
- Share repurchases of 189,166 reduced equity.
- New share issuances of 2,039,358 increased equity.
- Other comprehensive income increased equity by 491,578.
- Other factors increased equity by 1,101,656.
Equity Change Factors (2023 to 2024)
| Factor | Impact | Contribution |
|---|---|---|
| Net Income | AU$-3.13 Million | -3471.61% |
| Share Repurchases | AU$189.17K | -209.81% |
| Share Issuances | AU$2.04 Million | +2261.93% |
| Other Comprehensive Income | AU$491.58K | +545.23% |
| Other Changes | AU$1.10 Million | +1221.89% |
| Total Change | AU$- | % |
Book Value vs Market Value Analysis
This analysis compares Opyl Ltd's book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.
Valuation Insights
Historical Price-to-Book Ratios
| Date | Book Value per Share | Market Price | P/B Ratio |
|---|---|---|---|
| 1996-06-30 | AU$1269.70 | AU$0.02 | x |
| 1997-06-30 | AU$1254.66 | AU$0.02 | x |
| 1998-06-30 | AU$1064.40 | AU$0.02 | x |
| 1999-06-30 | AU$999.99 | AU$0.02 | x |
| 2000-06-30 | AU$690.17 | AU$0.02 | x |
| 2001-06-30 | AU$624.23 | AU$0.02 | x |
| 2002-06-30 | AU$585.52 | AU$0.02 | x |
| 2003-06-30 | AU$525.18 | AU$0.02 | x |
| 2004-06-30 | AU$531.75 | AU$0.02 | x |
| 2005-06-30 | AU$25398.18 | AU$0.02 | x |
| 2006-06-30 | AU$681.04 | AU$0.02 | x |
| 2007-06-30 | AU$226.28 | AU$0.02 | x |
| 2008-06-30 | AU$19075.31 | AU$0.02 | x |
| 2009-06-30 | AU$-7.83 | AU$0.02 | x |
| 2010-06-30 | AU$0.12 | AU$0.02 | x |
| 2011-06-30 | AU$0.73 | AU$0.02 | x |
| 2012-06-30 | AU$0.28 | AU$0.02 | x |
| 2013-06-30 | AU$21.04 | AU$0.02 | x |
| 2014-06-30 | AU$14.51 | AU$0.02 | x |
| 2015-06-30 | AU$0.04 | AU$0.02 | x |
| 2016-06-30 | AU$0.92 | AU$0.02 | x |
| 2017-06-30 | AU$0.06 | AU$0.02 | x |
| 2018-06-30 | AU$0.15 | AU$0.02 | x |
| 2019-06-30 | AU$-0.02 | AU$0.02 | x |
| 2020-06-30 | AU$0.05 | AU$0.02 | x |
| 2021-06-30 | AU$0.05 | AU$0.02 | x |
| 2022-06-30 | AU$0.00 | AU$0.02 | x |
| 2023-06-30 | AU$0.00 | AU$0.02 | x |
| 2024-06-30 | AU$0.00 | AU$0.02 | x |
Capital Efficiency Dashboard
This dashboard shows how efficiently Opyl Ltd utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.
Capital Efficiency Insights
- Current Return on Equity (ROE): 0.00%
- The company may be facing challenges in efficiently utilizing shareholder equity.
- DuPont Analysis Breakdown:
- • Net Profit Margin: -787.15%
- • Asset Turnover: 0.97x
- • Equity Multiplier: 0.00x
- Recent ROE (0.00%) is above the historical average (-113.24%), indicating improving capital efficiency.
Historical Capital Efficiency Metrics
| Year | Return on Equity | Net Profit Margin | Asset Turnover | Equity Multiplier | Economic Value Added |
|---|---|---|---|---|---|
| 1996 | -41.75% | 0.00% | 0.00x | 1.10x | AU$-3.18 Million |
| 1997 | -12.87% | 0.00% | 0.00x | 1.03x | AU$-1.42 Million |
| 1998 | -5.98% | 0.00% | 0.00x | 1.01x | AU$-1.03 Million |
| 1999 | -9.71% | 0.00% | 0.00x | 1.11x | AU$-1.26 Million |
| 2000 | -5.41% | 0.00% | 0.00x | 1.03x | AU$-1.45 Million |
| 2001 | -7.66% | 0.00% | 0.00x | 1.08x | AU$-1.57 Million |
| 2002 | -5.09% | 0.00% | 0.00x | 1.05x | AU$-1.49 Million |
| 2003 | -7.52% | 0.00% | 0.00x | 1.03x | AU$-1.83 Million |
| 2004 | -6.20% | 0.00% | 0.00x | 1.16x | AU$-2.61 Million |
| 2005 | -51.08% | 0.00% | 0.00x | 1.10x | AU$-8.19 Million |
| 2006 | -4.57% | 0.00% | 0.00x | 1.03x | AU$-7.59 Million |
| 2007 | -2.53% | -603.60% | 0.00x | 1.35x | AU$-7.47 Million |
| 2008 | -6.16% | 0.00% | 0.00x | 1.35x | AU$-11.21 Million |
| 2009 | 0.00% | 0.00% | 0.00x | 0.00x | AU$-73.27 Million |
| 2010 | 188.49% | 0.00% | 0.00x | 1.01x | AU$3.01 Million |
| 2011 | -2.27% | 0.00% | 0.00x | 1.11x | AU$-1.74 Million |
| 2012 | -42.86% | 0.00% | 0.00x | 1.02x | AU$-5.35 Million |
| 2013 | -24.29% | 0.00% | 0.00x | 1.04x | AU$-2.85 Million |
| 2014 | -46.17% | -552.75% | 0.08x | 1.03x | AU$-3.24 Million |
| 2015 | -337.77% | -7054.39% | 0.05x | 1.02x | AU$-4.61 Million |
| 2016 | -274.19% | -10855.33% | 0.02x | 1.10x | AU$-6.30 Million |
| 2017 | -1398.45% | -1470.92% | 0.35x | 2.72x | AU$-3.25 Million |
| 2018 | -217.77% | -734.11% | 0.20x | 1.46x | AU$-3.18 Million |
| 2019 | 0.00% | -334.94% | 2.81x | 0.00x | AU$-3.06 Million |
| 2020 | -128.76% | -149.17% | 0.66x | 1.30x | AU$-997.92K |
| 2021 | -52.25% | -148.88% | 0.31x | 1.14x | AU$-1.36 Million |
| 2022 | -781.25% | -231.16% | 0.92x | 3.67x | AU$-2.11 Million |
| 2023 | 0.00% | -279.33% | 0.87x | 0.00x | AU$-1.69 Million |
| 2024 | 0.00% | -787.15% | 0.97x | 0.00x | AU$-3.12 Million |
Industry Comparison
This section compares Opyl Ltd's net assets metrics with peer companies in the Health Information Services industry.
Industry Context
- Industry: Health Information Services
- Average net assets among peers: $19,142,795
- Average return on equity (ROE) among peers: -52.12%
Peer Company Comparison
| Company | Net Assets | Return on Equity | Debt-to-Equity | Market Cap |
|---|---|---|---|---|
| Opyl Ltd (OPL) | AU$-310.99K | -41.75% | N/A | $1.28 Million |
| Adheris Health Limited (AHE) | $51.58 Million | 1.54% | 0.92x | $119.94 |
| Alcidion Group Ltd (ALC) | $6.57 Million | -38.71% | 0.23x | $60.88 Million |
| ARTRYA Ltd (AYA) | $40.64 Million | -42.21% | 0.08x | $148.36 Million |
| Blinklab Ltd (BB1) | $6.48 Million | -27.04% | 0.06x | $39.10 Million |
| Beamtree Holdings Ltd (BMT) | $29.22 Million | 1.31% | 0.10x | $18.03 Million |
| Cogstate Ltd (CGS) | $29.02 Million | 24.18% | 1.36x | $124.86 Million |
| Careteq Ltd (CTQ) | $3.55 Million | -121.85% | 1.13x | $621.63K |
| Doctor Care Anywhere Group Plc (DOC) | $12.29 Million | -179.31% | 0.79x | $21.76 Million |
| Echoiq Ltd (EIQ) | $6.77 Million | -79.92% | 0.22x | $168.60 Million |
| Emyria Ltd (EMD) | $5.31 Million | -59.24% | 0.25x | $11.75 Million |